BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34714547)

  • 1. Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy.
    Koschade SE; Stratmann JA; Miesbach W; Steffen B; Serve H; Finkelmeier F; Brandts CH; Ballo O
    Eur J Haematol; 2022 Feb; 108(2):125-132. PubMed ID: 34714547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia.
    Chen CY; Tai CH; Tsay W; Chen PY; Tien HF
    Ann Oncol; 2009 Jun; 20(6):1100-4. PubMed ID: 19270342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S; Ge Y; Li Z; Yang T
    Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intracranial hemorrhage in adults with acute leukemia.
    Maze D; Al-Abri M; Farooq K; Atenafu EG; Nixon S; Lieberman L
    Transfusion; 2021 Dec; 61(12):3303-3308. PubMed ID: 34632602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial hemorrhage in adult patients with hematological malignancies.
    Chen CY; Tai CH; Cheng A; Wu HC; Tsay W; Liu JH; Chen PY; Huang SY; Yao M; Tang JL; Tien HF
    BMC Med; 2012 Aug; 10():97. PubMed ID: 22931433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and clinical characteristics of non-promyelocytic acute myeloid leukemia of intracerebral hemorrhage: A single center study in China.
    Zhang Q; Li X; Wei Z; Ye X; Zhu L; Xie M; Xie W; Zhu J; Li L; Zhou D; Zheng Y; Yang X; Zhu M; Sun J
    J Clin Neurosci; 2017 Oct; 44():203-206. PubMed ID: 28694043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
    JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
    Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
    BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristics and long-term outcomes of acute promyelocytic leukemia patients with early intracranial hemorrhage.
    Li H; Niu T; Huang J; Xie L; He C; Li J; Xiang B; Cui X; Wu Y; Tang Y; Jia Y; Liu Z; Ma H
    Int J Hematol; 2023 Apr; 117(4):538-543. PubMed ID: 36522588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial Hemorrhage in Patients with Hematologic Disorders: Prevalence and Predictive Factors.
    Owattanapanich W; Auewarakul CU
    J Med Assoc Thai; 2016 Jan; 99(1):15-24. PubMed ID: 27455820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and transfusion management following intracranial hemorrhage in patients with acute leukemia.
    Nixon S; Lieberman L; Atenafu EG; Doherty M; Murray C; Wolfe A; Brandys D; Rowland S; Kwan BY; Yu E; Lechner B; Maze D
    Transfusion; 2020 Feb; 60(2):269-274. PubMed ID: 31808560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk adapted therapeutic strategy in newly diagnosed acute myeloid leukemia: Refining the outcomes of ELN 2017 intermediate-risk patients.
    Mohty R; Massoud R; Chakhachiro Z; Mahfouz R; Nassif S; El-Cheikh J; Bazarbachi A; Abou Dalle I
    Leuk Res; 2021 Jun; 105():106568. PubMed ID: 33857784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of leukemia patients with intracranial hemorrhage. Clinical article.
    Chern JJ; Tsung AJ; Humphries W; Sawaya R; Lang FF
    J Neurosurg; 2011 Aug; 115(2):268-72. PubMed ID: 21568656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia.
    Zhang Y; Gu H; Chen Q; Zhang Y; Cheng H; Yang J; Wang J; Hu X
    Acta Haematol; 2020; 143(1):9-18. PubMed ID: 31167182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage.
    Chang MC; Chen TY; Tang JL; Lan YJ; Chao TY; Chiu CF; Ho HT
    Am J Hematol; 2007 Nov; 82(11):976-80. PubMed ID: 17636473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
    Ornstein MC; Mukherjee S; Mohan S; Elson P; Tiu RV; Saunthararajah Y; Kendeigh C; Advani A; Kalaycio M; Maciejewski JP; Sekeres MA
    Am J Hematol; 2014 Feb; 89(2):168-73. PubMed ID: 24123154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia - a nested case-control study.
    Cornelissen LL; Kreuger AL; Caram-Deelder C; Middelburg RA; Kerkhoffs JLH; von dem Borne PA; Beckers EAM; de Vooght KMK; Kuball J; Zwaginga JJ; van der Bom JG
    Ann Hematol; 2021 Jan; 100(1):261-271. PubMed ID: 33067700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease may be an early prognostic indicator for newly diagnosed acute myeloid leukemia patients induced by decitabine-based chemotherapy.
    Tan Y; Fu Y; Liu C; Sun J; Liu S; Lin H; Liu Q; Yang Y; Li Y; Su L; Gao S
    Hematology; 2019 Dec; 24(1):552-558. PubMed ID: 31315553
    [No Abstract]   [Full Text] [Related]  

  • 19. Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy.
    Koschade SE; Stratmann JA; Steffen B; Shaid S; Finkelmeier F; Serve H; Miesbach W; Brandts CH; Ballo O
    Eur J Haematol; 2023 Apr; 110(4):426-434. PubMed ID: 36573351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemia.
    Ross K; Gillespie-Twardy AL; Agha M; Raptis A; Hou JZ; Farah R; Redner RL; Im A; Duggal S; Ding F; Lin Y; Boyiadzis M
    Oncol Res; 2015; 22(2):85-92. PubMed ID: 25706395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.